Priced against the alternative.
Not the compute.
For an investor, the alternative is a diligence analyst’s weeks — or one bad deal that gets through. Zoe is a fraction of either. Exact pricing is being finalized; join the waitlist to lock in early-access terms.
Free
One outside-in scan.
- A public, outside-in read on any company
- A teaser Zoe Score and a few public-signal findings
- See the shape of the diagnostic before you commit
Investor
Full diagnostics + portfolio.
- Full evidence-backed diagnostics — Letter, findings, probe / price / walk
- Ask Zoe interrogation on every deal
- Export a branded PDF, copy an IC memo, share a codename-safe link
- Portfolio monitoring board across every company you own
Enterprise
Portfolio seats + the operator loop.
- Fund-wide seats with standardized portfolio scoring
- SSO, a security review, and an NDA / DPA
- Configurable scoring weights tuned to your thesis
- Operator quarterly loop and board pack (rolling out)
Depth is the ladder.
Every diagnostic runs on the data Zoe can read automatically today. As you grant more access — a data room, then live systems — coverage and confidence climb. You pay for how much of the company Zoe can actually see, not per seat-hour.
Zoe is pre-launch. Self-serve checkout and final pricing arrive with general availability — waitlist members get early-access terms and a guided first diagnostic.
Lock in early-access pricing.
Join the waitlist and we’ll set you up with a guided first diagnostic before general availability.
Join 200+ firms on the waitlist